Sep
30
Fri
2022
24th Annual Fogarty Lecture
Sep 30 @ 4:00 pm – 5:00 pm

Mir Imran has accepted the invitation to be the 24th annual Fogarty guest lecturer.  The date of the event is Friday September 30, 2022 at 4pm.  It will be a hybrid event.

Mir Imran, Chairman & CEO of InCube Labs, is a prolific healthcare innovator and entrepreneur, who has been developing and commercializing breakthrough medical innovations for over 40 years.

Mir began his career as a healthcare entrepreneur in the late 1970’s with his pioneering contributions to the first FDA-approved Implantable Defibrillator (ICD). Since then, Mir has founded more than 20 life sciences companies and two tech companies, 15 of which have seen liquidity events (IPO/Acquisition). His most recent exit, Rani Therapeutics Holdings Inc., went public on Nasdaq in July 2021.

Mir’s inventions have saved the lives of millions of patients, and many have become the standards of care. He has developed innovative therapies for a number of chronic diseases, including, anemia, chronic pain, stroke, diabetes, and several cardiovascular conditions. His recent company, Rani Therapeutics, is revolutionizing the management of chronic diseases, by replacing painful injectable therapies with oral biologics.

Mir holds more than 800 issued & pending US patents. In 2016, QMed named Mir as one of the “Top 50 Medical Inventors of All Time”. Mir is a fellow of the National Academy of Engineering, the National Academy of Inventors and the American Institute of Medical & Biological Engineers. In 2009, Mir was inducted into the Rutgers University Hall of Distinguished Alumni.

Mir is also the co-founder & managing director of InCube Ventures, LP, a medtech/biotech venture capital fund. In addition, Mir serves on the boards of several life science companies, on the advisory board of the Lemelson Foundation, and is a trustee of the UCSC Foundation. He is also an Adjunct Professor of Bioengineering at the University of Pittsburgh and actively supports the promotion and teaching of innovation and entrepreneurship at colleges and universities. As a philanthropist, Mir is passionately supporting education in India and US, especially for underprivileged students.

Oct
16
Sun
2022
American Society of Colon and Rectal Surgeons Meeting (ASCRS) Annual Meeting Abstract Deadline
Oct 16 all-day

The 2023 Abstract Submission Site is Now Open!

  SUBMIT AN ABSTRACT

Presentation Formats

  • Oral or ePoster: Abstracts submitted to this category will be competitively evaluated by the Program Committee for presentation in the oral, quick shot or ePoster format. Presentations selected will be eligible for annual awards including best overall, basic science or clinical paper presented from the podium or as an ePoster.
  • Oral Only: Abstracts submitted to this category will be competitively evaluated by the Program Committee for presentation in the oral format ONLY (Podium and Quick Shot). Abstracts will NOT be considered for ePoster presentation. Presentations selected will be eligible for annual awards including best overall, basic science or clinical paper presented from the podium.
  • ePoster Only: Abstracts submitted to this category will be evaluated for ePoster presentation only. Presentations selected will be eligible for best basic science or clinical e-poster.
  • Video: Abstracts submitted to this category will be competitively evaluated by the Video-Based Education Committee for presentation during the video abstract symposium and the Ongoing Video Room. Videos selected will be eligible for the best video award.
  • Case Study: Abstracts submitted to this category will be evaluated for ePoster presentation only.
  • Research Forum: Abstracts submitted to this category will be competitively evaluated by the Young Researchers Committee for oral presentation during the Research Forum. This session highlights developing areas of research that have clinical relevance for the care of patients with colorectal diseases. Presentations selected will be eligible for the Research in Progress award. If not accepted for Oral presentation the abstract will be considered for ePoster presentation.
  • New Technology: Abstracts submitted to this category will be competitively evaluated by the Program Committee in conjunction with the New Technologies Committee for oral presentation during the New Technology Symposium. This symposium highlights the development, integration, evaluation and dissemination of new technology in the practice of colon and rectal surgery. If not accepted for Oral presentation the abstract will be considered for e-poster presentation.

Feb
28
Tue
2023
Stanford Transplantation Surgical Fellowship Application Deadline
Feb 28 all-day
Apr
10
Mon
2023
The Pacific Association of Pediatric Surgeons Abstract Deadline
Apr 10 all-day
Nov
1
Wed
2023
The American Association of Endocrine Surgeons Annual Meeting Abstract Submission Deadline
Nov 1 all-day

 

Scientific Abstract submissions for the 2024 Annual Meeting is now OPEN.

ABSTRACT SUBMISSION DEADLINE:
Wednesday, November 1, 2023, 11:59 PM PST

Notifications will be sent to each submitting author in mid-to-late-December.

Important Reminders

  • The 2024 AAES Annual Meeting will be an in-person event in Dallas, Texas, USA. All presentations (Oral Podium and Poster) will be given in person.
  • Only original research will be considered (must not have been previously presented or published).
  • There is a 350-word limit for abstracts. NO GRAPHICS OR TABLES will be accepted with abstract submission.
  • The abstract copy MUST include the following: Background, Methods, Results, and Conclusion.
  • NO reference to the authors or the institution should appear within the title or body of the abstract.
  • Please do not submit case reports. A call for Interesting Case Submissions will be made after the abstract submission has been closed.
  • In accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME), authors will be required to disclose all financial relationships with any companies they have had over the past 24 months. Omission or misrepresentation of financial relationships is academic dishonesty. Evidence of such that is discovered before, during, or after the AAES Meeting will lead to the removal of the abstract from the program and the published proceedings, referral to the Ethics Committee and AAES Council for punitive action up to and including a ban from presenting at future AAES Meetings. For more information on the Standards for Integrity and Independence in Accredited Continuing Education, please visit accme.org/standards.
  • For trainees wishing to compete for the Van Heerden and Kinder Awards, select ‘yes’ to answer the relevant question. Submitted abstracts will be reviewed by the Program committee. The top abstracts will be selected for participation in the competition, and podium presentations will be scored during the scientific sessions. Abstracts selected for the competition will be denoted as such in the final program.